EI

Elizabeth Iorns

Founder of Transcripta Bio

San Francisco Bay Area

Overview 

Elizabeth Iorns is the CEO of Science Exchange in the San Francisco Bay Area, with a Ph.D. from The Institute of Cancer Research and a B.Sc (Hons) from The University of Auckland. She has been instrumental in co-founding Science Exchange and serving as its President & CEO, while also making significant contributions as a scientific founder and advisor at Transcripta Bio, a part-time partner at Y Combinator, and an angel investor in various companies. Iorns has achieved success by leading Science Exchange and investing in promising startups such as Unima, Enzyme, Torch, Validere, and Vetcove, showcasing her expertise in lifesciences, biotechnology, and entrepreneurship within the San Francisco Bay Area startup ecosystem.

Work Experience 

SE

Science Exchange

  • CEO & Co-founder

    2011 - Current

    Science Exchange is the first procurement and supplier orchestration cloud software platform for life sciences companies. The platform digitizes and streamlines complex procurement workflows spanning the entire purchasing lifecycle, from vendor and product discovery through purchasing and payment. Many of the world’s top pharma and biotech organizations rely on Science Exchange to help accelerate their research, automate manual processes, and advance their programs faster. For additional information on Science Exchange, please visit www.scienceexchange.com.

Science Exchange provides life sciences procurement and supplier management SaaS solutions.

Raised $77,500,000.00 from Norwest Venture Partners, Union Square Ventures, Collaborative Fund and Silicon Valley Bank.

scienceexchange.com
TB

Transcripta Bio

  • Scientific Founder & Advisor

    2020

    Transcripta Bio (formerly Rarebase) https://www.transcriptabio.com/

Transcripta Bio is a company that focuses on drug development at a size and pace never seen before, with a lower risk.

Raised $10,000,000.00 from BlueYard Capital and Jazz Venture Partners.

transcriptabio.com
YC

Y Combinator

  • Part-time partner

    2014 - 2020

    Helped to establish the "YC bio" program for early stage life science companies.

Various

  • Angel Investor

    2014 - 2020

    Angel investor in science, health and education companies including Asher Biotherapeutics, Avro Therapeutics, Hepatx, Enzyme, Curebase, Notable Labs, NURX, BIOS Health, Torch, Quero Education, Unima, Validere, Vetcove.

D(

DCAT (Drug, Chemical & Associated Technologies Association)

  • Board Director

    2017 - 2018

Uo

University of Miami

  • Assistant Professor

    2010 - 2011

  • Postdoctoral Associate

    2008 - 2010

Io

Institute of Cancer Research

  • Scientific Officer, Breakthrough Breast Cancer Research Center

    2003 - 2004

Education 

Investments 

Unima

Seed

Total funding: $2M

Enzyme

Seed

Total funding: $2.1M

Torch

Seed

Total funding: $86M

Validere

Seed

Total funding: $18M

Articles About Elizabeth

Relevant Websites